School of Psychology, University of Ulster Jordanstown, Co. Antrim, Northern Ireland
Division of Psychiatry and Neuroscience, Queens University Belfast, Northern Ireland
School of Psychological Sciences, University of Manchester, UK
Correspondence: Suzanne Barrett, Division of Psychiatry and Neuroscience, Queens University Belfast, Whitla Medical Building, 97 Lisburn Road, Belfast BT9 7BL, UK. Email: s.l.barrett{at}qub.ac.uk
Funded by the Research and Development Office (R & D Office), Northern Ireland.
Background
Researching psychotic disorders in unison rather than as separate diagnostic groups is widely advocated, but the viability of such an approach requires careful consideration from a neurocognitive perspective.
Aims
To describe cognition in people with bipolar disorder and schizophrenia and to examine how known causes of variability in individuals performance contribute to any observed diagnostic differences.
Method
Neurocognitive functioning in people with bipolar disorder (n = 32), schizophrenia (n = 46) and healthy controls (n = 67) was compared using analysis of covariance on data from the Northern Ireland First Episode Psychosis Study.
Results
The bipolar disorder and schizophrenia groups were most impaired on tests of memory, executive functioning and language. The bipolar group performed significantly better on tests of response inhibition, verbal fluency and callosal functioning. Between-group differences could be explained by the greater proclivity of individuals with schizophrenia to experience global cognitive impairment and negative symptoms.
Conclusions
Particular impairments are common to people with psychosis and may prove useful as endophenotypic markers. Considering the degree of individuals global cognitive impairment is critical when attempting to understand patterns of selective impairment both within and between these diagnostic groups.